top of page
Kynmobi (apomorphine hydrochloride) is used to treat acute, intermittent “off” episodes in patients who haveParkinson's Disease. Fact Table Formula C17H17NO2 License US DailyMed Bioavailability 100% Legal status Rx-Only Chemical Name Apomorphine HCI Elimination half-life 40 minutes Dosage (Strength) 10mg - 50mg Pregnancy Consult Doctor Brands Kynmobi Protein binding 50% PubChem CID 6005 MedlinePlus a604020 ChEBI 48538 ATC code G04BE07 DrugBank DB00714 KEGG D07460 Routes of administration Subcutaneous injection

Kynmobi (Apomorphine HCI) Sublingual film

  • Follow the instructions that come with your prescription. If you have any questions or concerns about your prescription, talk to your doctor or pharmacist. Your doctor may also prescribe a medication to help prevent nausea and vomiting that can occur with Kynmobi. Kynmobi is available as a sublingual film in the following strengths: 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg. Each Kynmobi film should be placed under the tongue. The films should not be cut, chewed, or swallowed. The typical dose is between 10 mg and 30 mg per dose as needed. Each dose should be separated by 2 hours or more. No more than 5 doses should be administered per day. No more than 30 mg should be taken at one time.
bottom of page